Remus Pharmaceuticals Limited IPO Review & Recommendations
Get Real-Time Updates on stock market trends and news
Get updates on stock market, Stock related news, Algo Trading, learn profitable strategies.
Join WhatsApp ChannelRemus Pharmaceuticals Limited IPO
May 17, 2023 - May 19, 2023
Closed
Apply with Angel One
Apply with Zerodha
Pre-Apply with Upstox
Remus Pharmaceuticals Limited IPO Review
Remus Pharmaceuticals Limited is engaged in the marketing and distribution of finished formulations of pharmaceutical drugs. This Company was incorporated in 2015. They provide technical consultancy services; Their Core strength lies in getting their approved formulation manufactured through a contract manufacturer under a loan license.
Their Competitive Strengths are a wide range of products, Strategic location of contract manufacturing, scalable business model, Diversified business operations, and Contract Manufacturing Facilities.
Remus Pharmaceuticals Limited Products and Services
Remus Pharmaceuticals Limited deals with API, (Active Pharmaceuticals Ingredient). This Company is classified into two categories. API- is the biologically active component of the drug product like cream, tablet, capsule, and injectable. Finished pharmaceuticals formulation- are therapeutic drugs available in different dosage forms. They deal in drugs, capsules, Eye drops, Gel, Inhalers, Injections, nasal Spray, Ointment, Oral solutions, and Suspension Tablets. Their Business Strategy is to Leverage their market skills & Relationship, and Improve global presence, increase brand visibility, Customer satisfaction, Maintain over the competitors.
Financial Overview
This company is highly competitive and has pharma product distribution with third-party contracts under B2B Model. Its profit margins are non-convincing. Based on profits the issue appears fully priced. There is no harm to skip this pricey IPO.
Frequently Asked Question
Minimum and maximum order quantity is 1 lot only.
Remus Pharmaceuticals Limited IPO shares will get listed on May 29, 2023.
Face value of Remus Pharmaceuticals Limited IPO is ₹10 per share.
Remus Pharmaceuticals Limited IPO Shares will get listed at NSE SME.
Closing date of Remus Pharmaceuticals Limited IPO is May 19, 2023.
Lot size of the Remus Pharmaceuticals Limited IPO is 2000 shares.
If you do not get the allotment of Remus Pharmaceuticals Limited IPO shares, your IPO application amount will be released or credited back to your bank account via which you applied for this IPO.
Pre-issue shareholding of the Remus Pharmaceuticals Limited IPO promoter is 92.82%.
If allotted, you will receive Remus Pharmaceuticals Limited IPO shares in your Demat account on May 26, 2023.
Remus Pharmaceuticals Limited IPO share price ₹1150 to ₹1229 per share.
Opening date of Remus Pharmaceuticals Limited IPO is May 17, 2023.
Post-issue shareholding of the Remus Pharmaceuticals Limited IPO promoter is 68.37%.
IPO application is an online process by using UPI or ASBA as a payment method. ASBA IPO application is already available in the net banking of your respective bank account and the UPI application is offered by your Stockbroker, you can invest in SVS Limited IPO using any neatest method at your convenience.
Comments for Remus Pharmaceuticals Limited IPO Review & Recommendations
0 comments